Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-08-002693
Filing Date
2008-03-13
Accepted
2008-03-13 17:21:12
Documents
9
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a2183558z10-k.htm 10-K 1232709
2 EXHIBIT 10.73 a2183558zex-10_73.htm EX-10.73 166221
3 EXHIBIT 21.1 a2183558zex-21_1.htm EX-21.1 2421
4 EXHIBIT 23.1 a2183558zex-23_1.htm EX-23.1 3308
5 EXHIBIT 31.1 a2183558zex-31_1.htm EX-31.1 7242
6 EXHIBIT 31.2 a2183558zex-31_2.htm EX-31.2 7235
7 EXHIBIT 32.1 a2183558zex-32_1.htm EX-32.1 5238
8 G1028711.JPG g1028711.jpg GRAPHIC 36920
9 G234310.JPG g234310.jpg GRAPHIC 17616
  Complete submission text file 0001047469-08-002693.txt   1501182
Mailing Address 1896 RUTHERFORD ROAD CARLSBAD CA 92008
Business Address 1896 RUTHERFORD ROAD CARLSBAD CA 92008 7609319200
ISIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19125 | Film No.: 08686936
SIC: 2834 Pharmaceutical Preparations